Fellows are expected to complete a minimum of one research project, leading to abstract publication, or develop a full IRB approved protocol during their training. Research efforts will vary a great deal depending on the fellow from a very few months up to 18 months dedicated time, depending on interest and funding.
Fellows will choose a mentor early in their first year and learn research methodology in practical ways by developing and pursuing a project of interest. Large patient data banks are available to review questions of interest. Our program is linked with a multi-institutional national research network (ACORN) which provides the opportunity to design investigator initiated clinical trials. The University of Tennessee and St Jude’s research hospital provide pathways toward bench and translational research as well.
Below are listed some of the abstracts and publications our most recent fellows have completed during their time in the program:
Obiageli Uchenna Ogbata, Xinhua Yu, Raymond U Osarogiagbon; University of Tennessee Health Science Center, Memphis, TN; University of Memphis, School of Public Health, Memphis, TN; Boston Baskin Cancer Foundation, Germantown, TN. (ASCO) Prognostic impact of the number of examined lymph nodes (LNs) in resected node negative (pNo) non-small cell lung cancer (NSCLC). Abstract #7025. Poster discussion session, 2012 ASCO Annual Meeting. June, 2012.
R. U. Osarogiagbon, Robert A. Ramirez, Christopher Wang, Laura Elizabeth Miller, Mansoor Ul-Haq, Aamer Farooq, Jeffrey Warren Allen, David Spencer, Allen Berry, Alva Bowen Weir III, Hammond Cole, Thomas O'Brien. (ASCO) Survival analysis of patients with/without lymph node examination after lung cancer resection.
Christopher Gene Wang, Laura Elizabeth Miller, Robert A. Ramirez, Michelle T Chi, Mansoor Ul-Haq, Rafael A Arteta-Bulos, Aamer Farooq, Jeffrey Warren Allen, Alva Bowen Weir III, Hammond Cole, Thomas O'Brien, R. U. Osarogiagbon. (ASCO) Comparison of survival between the American Joint Committee on Cancer (AJCC) 6 and 7 lung cancer staging systems in a resection cohort.
Naini, Pranitha. Hemoglobin Chicago, a rare variant of Alpha Thalassemia. SGIM 35th Annual Meeting, Poster presentation ID #: 1309280. Clinical Vignette Poster Session 1, May 10, 2012.
Azari LM, Sheehan VA. Sachdev JC and Jones TS. Dantrolene sodium for the treatment of interleukin 2 induced rigors for a melanoma patient: a case report and review of the literature. Annals of Pharmacotherapy, accepted.
Snider, Jessica. Retrospective Review of DPace Therapy as a salvage regimen in patients with relapsed multiple myeloma prior to autologous stem cell transplant. BMT Tandem Meetings, Poster presentation. February 1, 2012.
- Drs. Ogbeide and Lawson review clinic notes
- Dr. Osa Ogbeide
- Drs. Snider and Ogbata
- 2nd Year Fellows
- Dr. Bojia Li presents at Journal Club
- 1st Year Fellows
- 3rd Year Fellows
- Drs. Haq and Pandey discuss patient care
- Dr. Chesney leads the Hematology Symposium
Division of Hematology & Oncology
956 Court St.
Coleman Building H314
Memphis, Tennessee 38163
Janet Herriman, Coordinator: firstname.lastname@example.org